πŸ‡ΊπŸ‡Έ FDA
Patent

US 6479498

Sodium channel drugs and uses

expired A61KA61K47/55

Quick answer

US patent 6479498 (Sodium channel drugs and uses) held by Theravance, Inc. expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K47/55